Electromed Stock Today
| ELMD Stock | USD 14.65 0.11 0.76% |
Performance11 of 100
| Odds Of DistressLess than 8
|
Electromed is trading at 14.65 as of the 16th of April 2024, a 0.76 percent increase since the beginning of the trading day. The stock's lowest day price was 14.12. Electromed has only a 8 % chance of going through financial distress over the next few years and had a good performance during the last 90 days. Equity ratings for Electromed are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 17th of March 2024 and ending today, the 16th of April 2024. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 13th of August 2010 | Category Healthcare | Classification Health Care |
Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation therapy in pulmonary care for patients of various ages in the United States and internationally. The company has 8.61 M outstanding shares of which 42.93 K shares are currently shorted by private and institutional investors with about 1.06 trading days to cover. More on Electromed
Moving together with Electromed Stock
| 0.85 | ENSG | Ensign Group Financial Report 24th of April 2024 | PairCorr |
| 0.75 | COO | Cooper Companies Financial Report 6th of June 2024 | PairCorr |
| 0.96 | DVA | DaVita HealthCare Financial Report 13th of May 2024 | PairCorr |
Moving against Electromed Stock
| 0.8 | INNV | InnovAge Holding Corp Financial Report 14th of May 2024 | PairCorr |
| 0.75 | FIGS | Figs Inc Financial Report 2nd of May 2024 | PairCorr |
| 0.72 | LUCY | Innovative Eyewear | PairCorr |
| 0.72 | MMSI | Merit Medical Systems Financial Report 24th of April 2024 | PairCorr |
| 0.61 | XRAY | Dentsply Sirona Financial Report 1st of May 2024 | PairCorr |
| 0.6 | AGL | agilon health Financial Report 14th of May 2024 | PairCorr |
| 0.46 | ACHC | Acadia Healthcare Financial Report 24th of April 2024 | PairCorr |
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores
Electromed Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Electromed's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Electromed or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO and President and Director | Kathleen Skarvan | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Thematic Idea | Medical Equipment (View all Themes) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, Medical Equipment, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation Analysts covering Electromed report their recommendations after researching Electromed's financial statements, talking to executives and customers, or listening in on Electromed's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Electromed. The Electromed consensus assessment is calculated by taking the average forecast from all of the analysts covering Electromed. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Financial Strength Based on the measurements of operating efficiency obtained from Electromed's historical financial statements, Electromed is not in a good financial situation at this time. It has a very high probability of going through financial hardship in May. Financial strength of Electromed is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Electromed's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Electromed's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Electromed's financial leverage. It provides some insight into what part of Electromed's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Electromed (ELMD) is traded on NYSE MKT Exchange in USA. It is located in 500 Sixth Avenue NW, New Prague, MN, United States, 56071 and employs 170 people. Electromed is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 126.07 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Electromed's market, we take the total number of its shares issued and multiply it by Electromed's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Electromed conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 8.61 M outstanding shares of which 42.93 K shares are currently shorted by private and institutional investors with about 1.06 trading days to cover.
Electromed currently holds about 8.15 M in cash with 1.31 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.96.
Check Electromed Probability Of Bankruptcy
Ownership AllocationThe market capitalization of Electromed is $126.07 Million. Electromed retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please take into account that even companies with profitable outlook can generate negative future returns on their equity. If the true value of the firm is less than the current market value, you may not be able generate positive returns on investment in the long run.
Check Electromed Ownership Details
Electromed Stock Price Odds Analysis
What are Electromed's target price odds to finish over the current price? Based on a normal probability distribution, the odds of Electromed jumping above the current price in 90 days from now is about 37.35%. The Electromed probability density function shows the probability of Electromed stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days the stock has a beta coefficient of 1.6056 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Electromed will likely underperform. Additionally, electromed has an alpha of 0.5424, implying that it can generate a 0.54 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
Based on a normal probability distribution, the odds of Electromed to move above the current price in 90 days from now is about 37.35 (This Electromed probability density function shows the probability of Electromed Stock to fall within a particular range of prices over 90 days) .
Electromed Historical Income Statement
Electromed Income Statement is one of the three primary financial statements used for reporting Electromed's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Electromed revenue and expense. Electromed Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At present, Electromed's Total Revenue is projected to increase significantly based on the last few years of reporting. The current year's Gross Profit is expected to grow to about 44.1 M, whereas Interest Expense is forecasted to decline to about 85.2 K. View More FundamentalsElectromed Stock Against Markets
Picking the right benchmark for Electromed stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Electromed stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Electromed is critical whether you are bullish or bearish towards Electromed at a given time. Please also check how Electromed's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Electromed without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Piotroski F Score Now
Piotroski F ScoreGet Piotroski F Score based on the binary analysis strategy of nine different fundamentals |
| All Next | Launch Module |
Electromed Corporate Directors
Electromed corporate directors refer to members of an Electromed board of directors. The board of directors generally takes responsibility for the Electromed's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Electromed's board members must vote for the resolution. The Electromed board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Thomas Hagedorn | Independent Director | Profile | |
| Stan Erickson | Independent Director | Profile | |
| William Eckles | Independent Director | Profile | |
| Lee Jones | Director | Profile |
How to buy Electromed Stock?
Before investing in Electromed, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Electromed. To buy Electromed stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Electromed. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Electromed stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Electromed stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Electromed stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Electromed, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Electromed Stock please use our How to Invest in Electromed guide.
Already Invested in Electromed?
The danger of trading Electromed is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Electromed is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Electromed. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Electromed is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Electromed is a strong investment it is important to analyze Electromed's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Electromed's future performance. For an informed investment choice regarding Electromed Stock, refer to the following important reports: Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Electromed. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. For information on how to trade Electromed Stock refer to our How to Trade Electromed Stock guide.You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Complementary Tools for Electromed Stock analysis
When running Electromed's price analysis, check to measure Electromed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Electromed is operating at the current time. Most of Electromed's value examination focuses on studying past and present price action to predict the probability of Electromed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Electromed's price. Additionally, you may evaluate how the addition of Electromed to your portfolios can decrease your overall portfolio volatility.
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |
Is Electromed's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Electromed. If investors know Electromed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Electromed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.727 | Earnings Share 0.45 | Revenue Per Share 6.072 | Quarterly Revenue Growth 0.167 | Return On Assets 0.0721 |
The market value of Electromed is measured differently than its book value, which is the value of Electromed that is recorded on the company's balance sheet. Investors also form their own opinion of Electromed's value that differs from its market value or its book value, called intrinsic value, which is Electromed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Electromed's market value can be influenced by many factors that don't directly affect Electromed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Electromed's value and its price as these two are different measures arrived at by different means. Investors typically determine if Electromed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Electromed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.